Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Exc Stock Analysis Exelon Corporation Utility Sector Gains Hold Near 49.33 20260403 1 NUVL Nuvalent Inc reports widerthanexpected Q4 2025 loss shares edge 026 lower in postearnings trading PDCC Pearl Diver Credit Company Inc drops 271 after Q4 2025 EPS lands 3 below consensus analyst forecasts Is Agios AGIO Stock a LongTerm Buy 345 20260415 Tech Corp BTQ Climbs 894 Resistance at 322 in Focus 20260521 VNT Q1 2026 Earnings Slight EPS Miss Ahead of Market Expectations Is EUDA EUDA Undervalued at 1799 20260521 SoftBank Group Shares Surge 20 as Nvidia Earnings Fuel AI Optimism Rapid7 Publishes Q1 Threat Landscape Report Highlighting Key Cybersecurity Trends Indian Rupee Stages Sharp Recovery as RBI Intervention Provides Strong Support Subramanian Swamy Calls for Immediate Ban on Cement Imports from Pakistan Citing Security Risks Wall Street Edges Higher as Investors Closely Monitor Iran Peace Talks Trump Seeks Supreme Court Intervention to Delay TikTok Ban Market Watches Regulatory Crossroads Petraeus Says Iran May Be Blinking Over Strait of Hormuz Opening Door for Peace Deal FGBIP Q1 2026 Earnings Earnings Beat Estimates by Wide Margin Stock Nearly Flat QMCO Q1 2026 Earnings Adjusted EPS Surprises to the Upside Despite Stock Decline Opendoor Technologies OPEN Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Improvement WNC Q1 2026 Earnings EPS Falls Sharply Below Expectations as Operational Headwinds Persist ISPC Q3 2024 Earnings Significant EPS Miss Amid Operational Challenges EVLV Q1 2026 Earnings Narrow Loss Surprise Lifts Shares J J Snack Foods JJSF Holds Steady Near Support as Consolidation Continues Allegion ALLE Shows Mild Uptick as Support Levels Hold Firm Silicon Valley Acquisition Corp Warrants SVAQW Holds Steady Amid Consolidation Alarum Technologies ALAR Holds Steady Near Support as Bulls Test Resistance PharmaCyte Biotech PMCB Jumps 1276 as Biotech Speculation Heats Up